Supplementary Data 1 from A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma

Key points are not available for this paper at this time.

Representativeness of study participants.

Perguntar à IA

Bookmark

Perguntar à IA

Bookmark

Supplementary Data 1 from A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma | Synapse

Cite This Study

Kelly et al. (Mon,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data 1 from A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma2024
2

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data 1 from A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma2024
2

Data from A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma

2024